Illumina Inc

ILMN: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
%m%LOCK|%BC^dLOCK|ZJzSLv^

Illumina Earnings: Strong Instrument Sales and Growing AI Opportunities Boost 2026 Outlook

Illumina's second-quarter results included organic sales growth of just under 7% (up from 4% in the first quarter) and 10% adjusted EPS growth to $1.31, which was above FactSet consensus of $1.23. Management raised its 2026 outlook on these results.

Sponsor Center